FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First …

FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First … - FOXBusiness

FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First …
FOXBusiness - Apr 24, 2008
VYVANSE, introduced in July 2007 for the treatment of ADHD in children aged 6 to 12 years, is now the first and only once-daily prodrug stimulant approved …
Shire sees Vyvanse sales at bottom end ShareCast
Shire sales beat consensus; 2008 guidance confirmed, sees growth … Forbes
Shire: Vyvanse grows up Pharmaceutical Business Review
Investors Chronicle - Forbes
all 58 news articles

April 25th, 2008
Vyvanse

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner: